Mind Foundation
- Company typePrivate
- Founded2016
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
Mind Foundation firmographics
Firmographics- Name
- Mind Foundation
- Legal name
- MIND Foundation gGmbH
- Website
- https://mind-foundation.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Mind Foundation industry classification
Industry- Product category
- Psychedelic therapy research and education
- NAICS
- Scientific Research and Development Services (5417), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Engineering, Accounting, Research, Management (8700), Services-Membership Organizations (8600)
- akta.pro primary industry
- Meditation Apps, Digital Courses & Online Communities (HSADAJAH)
- akta.pro secondary industries
- Mindfulness, Meditation & Stress Management Education (EDAAAHAD), Mindfulness-Based Coaching & Training (MBSR/MBCT-style) (HSADAJAB), Mind-Body Wellness Coaching (Holistic/Integrative) (HSADAGAG)
Keywords
Where Mind Foundation is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Mind Foundation business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Fees: Standard Membership at €12/month (€120/year) or Access Membership at €6/month (€60/year). Both tiers offer identical benefits. Membership fees are tax-deductible as the MIND Members Association (Förderverein MIND Foundation e.V.) is a registered charitable association under German law.
- Training & Education Programs: The Augmented Psychotherapy Training (APT) is a 15-month professional program in psychedelic therapy for health professionals, available in English and German. Additional programs include Molecules (self-paced online course), Beyond Experience (integration workshop), and Footsteps (online integration course). Participation fees apply.
- Event Participation Fees: Revenue from INSIGHT Forum events, INSIGHT Conference, and uniMIND Symposium. Event fees support program delivery.
- Donations & Philanthropic Funding: Tax-deductible donations to the MIND Foundation gGmbH (recognized as charitable under German law). Donations via bank transfer or PayPal. The organization also receives government research grants (e.g., BMBF funding for the Acceptance Study).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Standard Membership - €12/month or €120/year |
| Subscription | Monthly | Access Membership - €6/month or €60/year |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
Mind Foundation product offering
Product offeringCore offering
MIND Foundation is a non-profit research and education organization that delivers professional therapist training (Augmented Psychotherapy Training/APT, 15 months), online public courses on psychopharmacology and psychedelic integration (Molecules, Beyond Experience, Footsteps), and runs clinical research studies including Phase IIb and Phase III psilocybin trials. It also operates a global community ecosystem through the uniMIND journal club network (32 clubs), MIND Members Association (48+ countries), MIND Community Platform digital hub, and the INSIGHT Forum and INSIGHT Conference event series, alongside clinical partner OVID Clinic Berlin.
Differentiator
Problem solved
Functional benefit
Brands
- uniMIND: Global network of academic journal clubs exploring psychedelic research, open to students, researchers, and curious thinkers from all disciplines.
- INSIGHT Forum
- INSIGHT Conference
- Augmented Psychotherapy Training (APT)
- Molecules
- Beyond Experience
- Footsteps
- MIND Community Platform (MCP)
- MIND Members Association
Products and services
- Augmented Psychotherapy Training (APT) A 15-month professional training program providing health professionals (doctors, psychiatrists, psychotherapists) with the knowledge and skills needed to practice psychedelic therapy in a legal, safe, and evidence-based framework.
- Molecules A self-paced online course exploring psychopharmacology in culture and society, available to the general public.
- Beyond Experience An integration workshop open to the general public for supporting reflection on psychedelic experiences.
- Footsteps An online integration course for personal development and psychedelic experience integration.
- uniMIND Journal Clubs A global network of 32 academic journal clubs exploring psychedelic research, connecting students, researchers, and curious thinkers through regular meetings and the annual uniMIND Symposium.
- INSIGHT Forum A public talk series exploring psychedelics in medicine and culture of consciousness, featuring three segments: Rationale (intellectual discourse), Transrationale (experience-based practices), and Communitas (networking).
- INSIGHT Conference An international, transdisciplinary conference series focused on research, therapy, and human development in relation to psychedelics, held biennially since 2019.
- MIND Community Platform (MCP) A digital hub for MIND Members providing discussion spaces, networks (uniMIND Journal Clubs, APT Network, Integration Circles, Local Meetups), sections (Neuroscience, Mental Health, Resonance, Philosophy, Arts, Policy & Law), and educational material.
- MIND Members Association A registered charitable association offering Standard Membership (€12/month or €120/year) and Access Membership (€6/month or €60/year), providing access to the MIND Community Platform, monthly Journal Clubs, Members Teach, Integration Circles, and Meetups.
Quantifiable outcome
- 192 health professionals enrolled or graduated from the APT psychedelic therapist training program
- +3 more outcomes
Companies that use Mind Foundation
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Mind Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature2 records
Mind Foundation partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, core and minor.
- INSIGHT ConferenceflagshipINSIGHT Conference is the largest conference on science and research into psychedelics in the German-speaking world, organized biennially by MIND Foundation since 2019. It is an international transdisciplinary conference covering research, therapy, and human development. The INSIGHT Forum event series is inspired by and connected to this conference.
- OVID Clinic BerlincoreOVID Clinic Berlin is MIND Foundation's clinical partner — an outpatient and day clinic integrating guideline therapies with novel psychedelic treatments. It is Europe's first psychedelic day clinic. Together they form a care ecosystem transforming mental health from treatment to growth. OVID Clinic also serves as a clinical trial site for psychedelic studies, and Dr. Henrik Jungaberle (CEO of MIND) is co-founder of OVID.
- Zentralinstitut für Seelische Gesundheit (ZI Mannheim)coreZentralinstitut für Seelische Gesundheit in Mannheim led the EPIsoDE Phase IIb clinical trial (144 patients, completed) investigating psilocybin for treatment-resistant depression, in cooperation with Charité Berlin and MIND Foundation. ZI Mannheim is also a consortium partner in the DiMension Phase III trial, which would be the largest psychedelic study ever conducted.
- Charité – Universitätsmedizin BerlincoreCharité Universitätsmedizin Berlin co-led the EPIsoDE Phase IIb clinical trial on psilocybin for treatment-resistant depression alongside ZI Mannheim and MIND Foundation. The trial was the largest publicly funded psilocybin study to date.
- SPRIN-D (Bundesagentur für Sprunginnovationen)flagshipSPRIN-D (German Federal Agency for Breakthrough Innovation) is a consortium partner in the DiMension Phase III clinical trial. The consortium aims to conduct the largest psychedelic study ever (700+ patients) and obtain regulatory approval and public reimbursement for psilocybin-assisted therapy in Europe.
- Usona InstituteflagshipUsona Institute is a consortium partner in the DiMension Phase III clinical trial alongside MIND Foundation, SPRIN-D, and ZI Mannheim. Usona is a non-profit psychedelic research organization working to advance psilocybin-based therapies through clinical trials and regulatory approval.
- BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)coreBfArM has authorized clinical trials at OVID Clinic Berlin for psychedelic substances on the pathway to drug approval, including studies on depression (5-MeO-DMT) and generalized anxiety disorder (LSD derivative).
- Essence Institute (Netherlands)minorDr. Sepideh Ravahi, a board member of the MIND Members Association, collaborates with the Essence Institute in the Netherlands where she facilitates legal psilocybin retreats. This represents a personal/professional connection rather than an institutional partnership.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Mind Foundation competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Mind Foundation social profiles
Digital presenceMind Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mind Foundation leadership team
Management profileNumber of profiles
Profiles4 records
Mind Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mind Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mind Foundation
What does Mind Foundation do?
MIND Foundation is a non-profit research and education organization that delivers professional therapist training (Augmented Psychotherapy Training/APT, 15 months), online public courses on psychopharmacology and psychedelic integration (Molecules, Beyond Experience, Footsteps), and runs clinical research studies including Phase IIb and Phase III psilocybin trials. It also operates a global community ecosystem through the uniMIND journal club network (32 clubs), MIND Members Association (48+ countries), MIND Community Platform digital hub, and the INSIGHT Forum and INSIGHT Conference event series, alongside clinical partner OVID Clinic Berlin.
Is Mind Foundation a public or private company?
Mind Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Mind Foundation founded?
Mind Foundation was founded in 2016. It employs 11 to 50 people.
Where is Mind Foundation based?
Mind Foundation is headquartered in Berlin, Germany, in the Europe region.
How does Mind Foundation make money?
Four revenue lines are on record. Membership Fees are the primary driver. The others are training & Education Programs, event Participation Fees and donations & Philanthropic Funding.
Does Mind Foundation have an API?
No public API is recorded for Mind Foundation.
What industry is Mind Foundation in?
Mind Foundation's product category is Psychedelic therapy research and education. Its primary akta.pro industry code is HSADAJAH, Meditation Apps, Digital Courses & Online Communities, with a secondary code of EDAAAHAD, Mindfulness, Meditation & Stress Management Education. Its NAICS code is 5417 and its SIC code is 8700.